Colottation Factor Ix Concentrate (Plasma-Derived Tender - 140280118

Procurement Summary

Country: Poland

Summary: Colottation Factor Ix Concentrate (Plasma-Derived or Recombinant) with Successive Deliveries to Regional Blood Donation and Blood Treatment Centers and Patients' Homes; Sign of Conduct:....

Deadline: 05 May 2026

Posting Date: 28 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 140280118

Document Ref. No.: 291424-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33621000 - Medicinal products for the blood and blood-forming organs

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

COLOTTATION FACTOR IX concentrate (PLASMA-DERIVED OR RECOMBINANT) with successive deliveries to Regional Blood Donation and Blood Treatment Centers and patients' homes; sign of conduct:.... COLOTTATION FACTOR IX concentrate (PLASMA DERIVED OR RECOMBINATE) with successive deliveries to Regional Blood Donation and Blood Treatment Centers and patients' homes; reference number: ZZP.ZP.411.51.2026 COLOTTATION FACTOR IX concentrate (PLASMA DERIVED OR RECOMBINANT) with successive deliveries to Regional Blood Donation and Treatment Centers and patients' homes The subject of the order includes successive deliveries of coagulation factor IX concentrate (plasma-derived or recombinant) in 2026-2027 to ensure continuity treatment of patients with hemophilia type B - hereinafter referred to as "coagulation factor", with the availability category Rp or Rpz, to direct recipients indicated by the National Blood Center (hereinafter NCK) or other authorized entity - Regional Blood Donation Centers and Blood Therapy (hereinafter referred to as RCKiK), as part of the health policy program of the minister responsible for health entitled "National Program for the Treatment of Patients with Hemophilia and Related Hemorrhagic Disorders for the years 2024-2028", hereinafter referred to as the "MZ program", as well as in the years 2026-2027 delivery of administration sets or infusion sets to vascular ports for patients indicated by the National Blood Center (hereinafter referred to as NCK) or other authorized entity, organization of deliveries to patients' homes, which is considered the place of residence or stay of a permanent patient, for the indicated number of patients, disposal of single-use equipment and control of drug consumption, on the terms specified...
Document Type: Contract Notice Reference Number: ZZP.ZP.411.51.2026 Contract Type: supplies Authority Type: cga Doc Title: COLOTTATION FACTOR IX concentrate (PLASMA-DERIVED OR RECOMBINANT) with successive deliveries to Regional Centers Blood Donation and Blood Treatment Center and patients' homes; reference number: ZZP.ZP.411.51.2026 Dispatch Date: 2026-04-27 Publish Date: 2026-04-28 Submission Date: 2026-05-05

Documents

 Tender Notice